Ramucirumab receives US FDA approval for use in advanced stomach cancer

Brown Emily

首页> 外文期刊>Future oncology >Ramucirumab receives US FDA approval for use in advanced stomach cancer

【24h】

Ramucirumab receives US FDA approval for use in advanced stomach cancer

机译：雷米库单抗获得美国FDA批准用于晚期胃癌

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Future oncology》 |2014年第8期|共1页
作者
Brown Emily;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Ramucirumab receives US FDA approval for use in advanced stomach cancer [J] . Brown Emily Future oncology . 2014,第8期

机译：雷米库单抗获得美国FDA批准用于晚期胃癌
2. FDA Approval Summary: Ramucirumab for Gastric Cancer [J] . Casak Sandra J., Fashoyin-Aje Ibilola, Lemery Steven J., Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第15期

机译：FDA批准摘要：雷米单抗用于胃癌
3. FDA Approval Summary: Ramucirumab for Gastric Cancer [J] . Casak Sandra J., Fashoyin-Aje Ibilola, Lemery Steven J., Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第15期

机译：FDA批准摘要：雷米单抗用于胃癌
4. Results of treatment of patients with stomach cancer advanced form treated by combination of lw level laser therapy (LLLT) and other methods (10-years experience) [C] . V.A.Mikhailov Conference on Laser Florence'99: A Window on the Laser Medicine World 28-31 October 1999 Florence, Italy . 1999

机译：低水平激光疗法（LLLT）和其他方法相结合治疗晚期胃癌患者的结果（10年经验）
5. Evidence Supporting FDA Approval and CMS National Coverage Determinations for Novel Medical Products, 2005 through 2016: A Cross-Sectional Study [D] . Roginiel, Aliya C. 2019

机译：证据支持FDA批准和CMS全国新型医疗产品的覆盖范围，2005年至2016年：横断面研究
6. Cosentyx (Secukinumab): First IL-17A Antagonist Receives FDA Approval for Moderate-to-Severe Plaque Psoriasis [O] . Loretta Fala 2016

机译：Cosentyx（Secukinumab）：首款IL-17A拮抗剂获得中度至重度斑块状牛皮癣的FDA批准
7. Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer [O] . Edith Borcoman, Christophe Le Tourneau 2020

机译：keynote-158研究，FDA授予Pembrolizumab的加速批准用于治疗晚期PD-L1阳性宫颈癌患者
8. Guidance for Industry. FDA Approval of New Cancer Treatment Uses for Marketed211 Drug and Biological Products [R] . 1998

机译：工业指南。 FDa批准新的癌症治疗用于市场上的211种药物和生物制品

Ramucirumab receives US FDA approval for use in advanced stomach cancer

著录项

相似文献

相关主题

期刊订阅